Light Mode
$0.2778 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2778, $0.0175 below the day’s high of $0.2953
-1.44 (-83.85%) / 6M
Momentum, market sentiment, and recent alerts
CODX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -29.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.